PDCD4 Knockdown Induces Senescence in Hepatoma Cells by Up-Regulating the P21 Expression

Overview

Journal Front Oncol

Specialty Oncology

Date 2019 Jan 29

PMID 30687637

Citations 9

Authors

Jing Guo

Iwata Ozaki

Jinghe Xia

Takuya Kuwashiro

Motoyasu Kojima

Hirokazu Takahashi

Kenji Ashida

Keizo Anzai

Sachiko Matsuhashi

Affiliations

Soon will be listed here.

Abstract

While the over-expression of tumor suppressor programmed cell death 4 (PDCD4) induces apoptosis, it was recently shown that PDCD4 knockdown also induced apoptosis. In this study, we examined the cell cycle regulators whose activation is affected by PDCD4 knockdown to investigate the contribution of PDCD4 to cell cycle regulation in three types of hepatoma cells: HepG2, Huh7 (mutant p53 and p16-deficient), and Hep3B (p53- and Rb-deficient). PDCD4 knockdown suppressed cell growth in all three cell lines by inhibiting Rb phosphorylation via down-regulating the expression of Rb itself and CDKs, which phosphorylate Rb, and up-regulating the expression of the CDK inhibitor p21 through a p53-independent pathway. We also found that apoptosis was induced in a p53-dependent manner in PDCD4 knockdown HepG2 cells (p53+), although the mechanism of cell death in PDCD4 knockdown Hep3B cells (p53-) was different. Furthermore, PDCD4 knockdown induced cellular senescence characterized by β-galactosidase staining, and p21 knockdown rescued the senescence and cell death as well as the inhibition of Rb phosphorylation induced by PDCD4 knockdown. Thus, PDCD4 is an important cell cycle regulator of hepatoma cells and may be a promising therapeutic target for the treatment of hepatocellular carcinoma.

Citing Articles

The Impact of Pdcd4, a Translation Inhibitor, on Drug Resistance.

Wang Q, Yang H Pharmaceuticals (Basel). 2024; 17(10).

PMID: 39459035 PMC: 11510623. DOI: 10.3390/ph17101396.

Human Bone Marrow Mesenchymal Stem Cells-Derived Exosomal miRNA-21-5p Inhibits Lidocaine-Induced Apoptosis in SH-SY5Y Neuroblastoma Cells.

Chen C, Zhu F, Liu F, Yao Y, Ma Z, Luo S Iran J Public Health. 2023; 52(4):756-765.

PMID: 37551179 PMC: 10404314. DOI: 10.18502/ijph.v52i4.12446.

Induction of premature senescence and a less-fibrogenic phenotype by programmed cell death 4 knockdown in the human hepatic stellate cell line Lieming Xu-2.

Perveen R, Ozaki I, Manirujjaman M, Mine K, Murata Y, Tanaka K Hum Cell. 2022; 36(2):583-601.

PMID: 36522523 PMC: 9947070. DOI: 10.1007/s13577-022-00844-9.

Proteomic Analysis of Hypoxia-Induced Senescence of Human Bone Marrow Mesenchymal Stem Cells.

Mai L, He G, Chen J, Zhu J, Chen S, Hou X Stem Cells Int. 2021; 2021:5555590.

PMID: 34484348 PMC: 8416403. DOI: 10.1155/2021/5555590.

Zinc Oxide Nanoparticles Can Intervene in Radiation-Induced Senescence and Eradicate Residual Tumor Cells.

Wiesmann N, Gieringer R, Viel M, Eckrich J, Tremel W, Brieger J Cancers (Basel). 2021; 13(12).

PMID: 34203835 PMC: 8232817. DOI: 10.3390/cancers13122989.

References

Sherr C, Roberts J . CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 1999; 13(12):1501-12. DOI: 10.1101/gad.13.12.1501. View

Soejima H, Miyoshi O, Yoshinaga H, Masaki Z, Ozaki I, KAJIWARA S . Assignment of the programmed cell death 4 gene (PDCD4) to human chromosome band 10q24 by in situ hybridization. Cytogenet Cell Genet. 2000; 87(1-2):113-4. DOI: 10.1159/000015408. View

Hanahan D, Weinberg R . The hallmarks of cancer. Cell. 2000; 100(1):57-70. DOI: 10.1016/s0092-8674(00)81683-9. View

Pucci B, Kasten M, Giordano A . Cell cycle and apoptosis. Neoplasia. 2000; 2(4):291-9. PMC: 1550296. DOI: 10.1038/sj.neo.7900101. View

Oda K, Arakawa H, Tanaka T, Matsuda K, Tanikawa C, Mori T . p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53. Cell. 2000; 102(6):849-62. DOI: 10.1016/s0092-8674(00)00073-8. View

Yang H, Jansen A, Nair R, Shibahara K, Verma A, Cmarik J . A novel transformation suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-kappaB or ODC transactivation. Oncogene. 2001; 20(6):669-76. DOI: 10.1038/sj.onc.1204137. View

Krtolica A, Parrinello S, Lockett S, Desprez P, Campisi J . Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging. Proc Natl Acad Sci U S A. 2001; 98(21):12072-7. PMC: 59769. DOI: 10.1073/pnas.211053698. View

Jin S, Levine A . The p53 functional circuit. J Cell Sci. 2001; 114(Pt 23):4139-40. DOI: 10.1242/jcs.114.23.4139. View

Te Poele R, Okorokov A, Jardine L, Cummings J, Joel S . DNA damage is able to induce senescence in tumor cells in vitro and in vivo. Cancer Res. 2002; 62(6):1876-83. View

10.

Roncalli M, Bianchi P, Bruni B, Laghi L, Destro A, Di Gioia S . Methylation framework of cell cycle gene inhibitors in cirrhosis and associated hepatocellular carcinoma. Hepatology. 2002; 36(2):427-32. DOI: 10.1053/jhep.2002.34852. View

11.

Classon M, Harlow E . The retinoblastoma tumour suppressor in development and cancer. Nat Rev Cancer. 2002; 2(12):910-7. DOI: 10.1038/nrc950. View

12.

Yang H, Jansen A, Komar A, Zheng X, Merrick W, Costes S . The transformation suppressor Pdcd4 is a novel eukaryotic translation initiation factor 4A binding protein that inhibits translation. Mol Cell Biol. 2002; 23(1):26-37. PMC: 140682. DOI: 10.1128/MCB.23.1.26-37.2003. View

13.

Vaziri C, Saxena S, Jeon Y, Lee C, Murata K, Machida Y . A p53-dependent checkpoint pathway prevents rereplication. Mol Cell. 2003; 11(4):997-1008. DOI: 10.1016/s1097-2765(03)00099-6. View

14.

Roninson I . Tumor cell senescence in cancer treatment. Cancer Res. 2003; 63(11):2705-15. View

15.

Chen Y, Knosel T, Kristiansen G, Pietas A, Garber M, Matsuhashi S . Loss of PDCD4 expression in human lung cancer correlates with tumour progression and prognosis. J Pathol. 2003; 200(5):640-6. DOI: 10.1002/path.1378. View

16.

Yang H, Cho M, Zakowicz H, Hegamyer G, Sonenberg N, Colburn N . A novel function of the MA-3 domains in transformation and translation suppressor Pdcd4 is essential for its binding to eukaryotic translation initiation factor 4A. Mol Cell Biol. 2004; 24(9):3894-906. PMC: 387765. DOI: 10.1128/MCB.24.9.3894-3906.2004. View

17.

Itahana K, Campisi J, Dimri G . Mechanisms of cellular senescence in human and mouse cells. Biogerontology. 2004; 5(1):1-10. DOI: 10.1023/b:bgen.0000017682.96395.10. View

18.

Goke R, Barth P, Schmidt A, Samans B, Lankat-Buttgereit B . Programmed cell death protein 4 suppresses CDK1/cdc2 via induction of p21(Waf1/Cip1). Am J Physiol Cell Physiol. 2004; 287(6):C1541-6. DOI: 10.1152/ajpcell.00025.2004. View

19.

Bitomsky N, Bohm M, Klempnauer K . Transformation suppressor protein Pdcd4 interferes with JNK-mediated phosphorylation of c-Jun and recruitment of the coactivator p300 by c-Jun. Oncogene. 2004; 23(45):7484-93. DOI: 10.1038/sj.onc.1208064. View

20.

Afonja O, Juste D, Das S, Matsuhashi S, Samuels H . Induction of PDCD4 tumor suppressor gene expression by RAR agonists, antiestrogen and HER-2/neu antagonist in breast cancer cells. Evidence for a role in apoptosis. Oncogene. 2004; 23(49):8135-45. DOI: 10.1038/sj.onc.1207983. View